Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian A Bergmark

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Circulation|April 4, 2022
Effect of Vupanorsen on Non-High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70Brian A Bergmark, Nicholas A Marston, Candace R Bramson, et al.
The New England Journal of Medicine|April 8, 2024
Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular RiskBrian A Bergmark, Nicholas A Marston, Thomas A Prohaska, et al.
Journal of the American College of Cardiology|August 25, 2022
Biomarker Prediction of Complex Coronary Revascularization Procedures in the FOURIER TrialAntonio Fagundes, David A Morrow, Kazuma Oyama, et al.
American Heart Journal|March 13, 2025
Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk: Rationale and design of the Essence-TIMI 73b trialBrian A Bergmark, Nicholas A Marston, Thomas A Prohaska, et al.
Journal of Clinical Lipidology|December 29, 2023
Hepatic fat changes with antisense oligonucleotide therapy targeting ANGPTL3Andre Zimerman, Stephen D Wiviott, Jeong-Gun Park, et al.
European Journal of Preventive Cardiology|March 14, 2024
Reductions in remnant cholesterol and VLDL cholesterol through inhibition of ANGPTL3 protein synthesis: an analysis from the TRANSLATE-TIMI 70 trialAndre Zimerman, Stephen D Wiviott, Jeong-Gun Park, et al.
JAMA Cardiology|May 31, 2023
Percutaneous Coronary Intervention vs Coronary Artery Bypass Graft Surgery for Left Main Disease in Patients With and Without Acute Coronary Syndromes: A Pooled Analysis of 4 Randomized Clinical TrialsPrakriti Gaba, Evald H Christiansen, Per H Nielsen, et al.
Lancet (London, England)|November 18, 2021
Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysisMarc S Sabatine, Brian A Bergmark, Sabina A Murphy, et al.
The New England Journal of Medicine|September 1, 2025
Targeting <i>APOC3</i> with Olezarsen in Moderate HypertriglyceridemiaBrian A Bergmark, Nicholas A Marston, Thomas A Prohaska, et al.
Circulation|March 11, 2024
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main Disease With and Without Diabetes: Findings From a Pooled Analysis of 4 Randomized Clinical TrialsPrakriti Gaba, Joseph F Sabik, Sabina A Murphy, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Circulation|April 4, 2022
Effect of Vupanorsen on Non-High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70Brian A Bergmark, Nicholas A Marston, Candace R Bramson, et al.
The New England Journal of Medicine|April 8, 2024
Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular RiskBrian A Bergmark, Nicholas A Marston, Thomas A Prohaska, et al.
Journal of the American College of Cardiology|August 25, 2022
Biomarker Prediction of Complex Coronary Revascularization Procedures in the FOURIER TrialAntonio Fagundes, David A Morrow, Kazuma Oyama, et al.
American Heart Journal|March 13, 2025
Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk: Rationale and design of the Essence-TIMI 73b trialBrian A Bergmark, Nicholas A Marston, Thomas A Prohaska, et al.
Journal of Clinical Lipidology|December 29, 2023
Hepatic fat changes with antisense oligonucleotide therapy targeting ANGPTL3Andre Zimerman, Stephen D Wiviott, Jeong-Gun Park, et al.
European Journal of Preventive Cardiology|March 14, 2024
Reductions in remnant cholesterol and VLDL cholesterol through inhibition of ANGPTL3 protein synthesis: an analysis from the TRANSLATE-TIMI 70 trialAndre Zimerman, Stephen D Wiviott, Jeong-Gun Park, et al.
JAMA Cardiology|May 31, 2023
Percutaneous Coronary Intervention vs Coronary Artery Bypass Graft Surgery for Left Main Disease in Patients With and Without Acute Coronary Syndromes: A Pooled Analysis of 4 Randomized Clinical TrialsPrakriti Gaba, Evald H Christiansen, Per H Nielsen, et al.
Lancet (London, England)|November 18, 2021
Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysisMarc S Sabatine, Brian A Bergmark, Sabina A Murphy, et al.
The New England Journal of Medicine|September 1, 2025
Targeting <i>APOC3</i> with Olezarsen in Moderate HypertriglyceridemiaBrian A Bergmark, Nicholas A Marston, Thomas A Prohaska, et al.
Circulation|March 11, 2024
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main Disease With and Without Diabetes: Findings From a Pooled Analysis of 4 Randomized Clinical TrialsPrakriti Gaba, Joseph F Sabik, Sabina A Murphy, et al.
Pageof 8